当代医学
噹代醫學
당대의학
CHINA CONTEMPORARY MEDICINE
2013年
4期
3-4
,共2页
高血压病%组织型纤溶酶原激活剂%组织型纤溶酶原抑制剂
高血壓病%組織型纖溶酶原激活劑%組織型纖溶酶原抑製劑
고혈압병%조직형섬용매원격활제%조직형섬용매원억제제
Essential hypertension%t-PA(Tissue-Plasminogen Activator)%PAI-1(Plasminogen Activator Inhibitor-1)
目的探讨中老年高血压病患者在血压控制(苯磺酸氨氯地平)良好基础上小剂量阿司匹林对其纤溶活性的进一步影响.方法将40例高血压病患者随机分为处理组(治疗后4周加服ASA,100 mg,qn,)和对照组(不加服ASA).采用酶联免疫吸附法(ELISA)测定组织型纤溶酶原激活剂(t-PA)及组织型纤溶酶原抑制剂(PAI-1)的抗原含量,比较组间、组内的差别.结果处理组和对照组组内前后两两进行比较,t-PA和PAI-1抗原含量下降程度,均有统计学意义(P<0.01).与对照组同一时间点比较,处理组在治疗后4周,t-PA抗原含量下降,有统计学意义(P<0.01);处理组在加服ASA 4周后,t-PA抗原含量虽有下降,但无统计学意义(P>0.05);PAI-1抗原含量有进一步下降,且有统计学意义(P<0.01).结论高血压病患者存在纤溶及抗纤溶系统的失衡;苯磺酸氨氯地平可改善纤溶功能;阿司匹林通过影响PAI-1来进一步改善纤溶功能.
目的探討中老年高血壓病患者在血壓控製(苯磺痠氨氯地平)良好基礎上小劑量阿司匹林對其纖溶活性的進一步影響.方法將40例高血壓病患者隨機分為處理組(治療後4週加服ASA,100 mg,qn,)和對照組(不加服ASA).採用酶聯免疫吸附法(ELISA)測定組織型纖溶酶原激活劑(t-PA)及組織型纖溶酶原抑製劑(PAI-1)的抗原含量,比較組間、組內的差彆.結果處理組和對照組組內前後兩兩進行比較,t-PA和PAI-1抗原含量下降程度,均有統計學意義(P<0.01).與對照組同一時間點比較,處理組在治療後4週,t-PA抗原含量下降,有統計學意義(P<0.01);處理組在加服ASA 4週後,t-PA抗原含量雖有下降,但無統計學意義(P>0.05);PAI-1抗原含量有進一步下降,且有統計學意義(P<0.01).結論高血壓病患者存在纖溶及抗纖溶繫統的失衡;苯磺痠氨氯地平可改善纖溶功能;阿司匹林通過影響PAI-1來進一步改善纖溶功能.
목적탐토중노년고혈압병환자재혈압공제(분광산안록지평)량호기출상소제량아사필림대기섬용활성적진일보영향.방법장40례고혈압병환자수궤분위처리조(치료후4주가복ASA,100 mg,qn,)화대조조(불가복ASA).채용매련면역흡부법(ELISA)측정조직형섬용매원격활제(t-PA)급조직형섬용매원억제제(PAI-1)적항원함량,비교조간、조내적차별.결과처리조화대조조조내전후량량진행비교,t-PA화PAI-1항원함량하강정도,균유통계학의의(P<0.01).여대조조동일시간점비교,처리조재치료후4주,t-PA항원함량하강,유통계학의의(P<0.01);처리조재가복ASA 4주후,t-PA항원함량수유하강,단무통계학의의(P>0.05);PAI-1항원함량유진일보하강,차유통계학의의(P<0.01).결론고혈압병환자존재섬용급항섬용계통적실형;분광산안록지평가개선섬용공능;아사필림통과영향PAI-1래진일보개선섬용공능.
Objective To reserch the impact of low-dose aspirin on fibrinolytic activity in patients with essential hypertension based on blood pressure control well. Methods Forty cases of patients with essential hypertension were divided into control group whose non-taking Bayaspirin and treatment group whose taking bayaspirin(ASA, 100 mg, qn) by random number table. At beginning, the blood pressure controlled well and their good blood pressure after four weeks, The antigen content of t-PA(Tissue-Plasminogen Activator) and PAI-1 (Plasminogen Activator nhibitor-1) in the serum whose forty cases of patients with essential hypertension were detected by ELISA to compare the treatment group with the control group. The experimental data was indicated by mean±standard (x±s). Results Forty cases with essential hypertension will be divided into control group and treatment group by random number table. Compared with before treatment, the plasma t-PA level and PAI-1 level were both significantly decreased(P<0.01) in two groups after conventional antihypertensive therapy. Compared to the control group of conventional antihypertensive therapy after eight weeks, the PAI-1 level whose the treatment group with taking aspirin after four weeks was more pronounced decline (P<0.01). The t-PA level was also decreased, but the comparison between control group and treatment group was not significant(P>0.05).At beginning , the blood pressure controlled well and their good blood pressure after four weeks, the plasma t-PA level and PAI-1 level were decile significantly in inter-group of the treatment group or the control group(P<0.01).Conclusion There is endogenous fibrinolysis disturbance in essential hypertension and antihypertensive treatment may improve fibrinolytic activity. Asipirin can be further improved fibrinolytic activity by influencing PAI-1.